DB

Devidas Boyer

Active Director Director DIN 08592867
DIN 08592867 First appointment Oct 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Devidas Boyer

Data last updated:

Devidas Boyer is a Director at Homize Health (Opc) Private Limited (since 2019). The company operates in Healthcare. Homize Health (Opc) Private Limited reported revenue of ₹2,480 (FY 2022).

DIN 08592867
Primary Designation Director
Industry Healthcare
First Appointment 22 Oct 2019
Oldest Company Age 7 yrs
Largest company Homize Health (Opc) Private Limited · ₹2,480 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Homize Health (Opc) Private Limited U85195TG2019OPC136253
Director22 Oct 20192019₹2,480 (FY 2022)Active

Directorship timeline

Open interactive timeline →
Homize Health (Opc) Private Limited
Premium access

Shareholding and investment profile for Devidas Boyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devidas Boyer

Devidas Boyer currently holds 1 directorship: Homize Health (Opc) Private Limited (Director, since 22 Oct 2019, revenue ₹2,480 (FY 2022)).

Devidas Boyer was first appointed on 22 Oct 2019 as Director at Homize Health (Opc) Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available